Aligos Therapeutics, Inc.

Aligos Therapeutics, Inc. financial statements

Aligos Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 2.19M10-K
Net income−USD 24.19M10-K
Cash and equivalentsUSD 18.3M10-Q
Total debtUSD 5.25MEODHD

Aligos Therapeutics, Inc. financials on 6ix · Aligos Therapeutics, Inc. on 6ix